logo

For the Inventor, By the Inventor

Lake Bluff, IL, United States of America

Mou-Ying Fu Lu

This inventor holds 7 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1989-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mou-Ying Fu Lu. Retrieved from https://idiyas.com/inventor/mou-ying-fu-lu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 7

Forward Citations = 292(Granted Patents)


Company Filing History:

goldMedal7 out of 4,187 
 
Abbott Laboratories Corporation
 patents

Years Active: 1989-1998

Loading Chart...
7 patents (USPTO):Explore Patents
1. 5853740 - Delivery system for pharmaceutical agents encapsulated with oils (1998-12-29),
2. 5676931 - Aerosol drug formulations for use with non CFC propellants (1997-10-14),
3. 5635159 - Aerosol drug formulations containing polyglycolyzed glycerides (1997-06-03),
4. 5487898 - Compositions and method for the sublingual or buccal administration (1996-01-30),
5. 5446025 - Formulations and method of the percutaneous administration of leuprolide (1995-08-29),
6. 5284657 - Compositions and methods for the sublingual or buccal administration of (1994-02-08),
7. 4808411 - Antibiotic-polymer compositions (1989-02-28),

Title: The Innovative Contributions of Mou-Ying Fu Lu

Introduction

Mou-Ying Fu Lu is a notable inventor based in Lake Bluff, IL (US). He has made significant contributions to the field of pharmaceuticals, holding a total of 7 patents. His work focuses on developing advanced delivery systems for pharmaceutical agents, enhancing the efficacy and safety of medications.

Latest Patents

One of his latest patents is a delivery system for pharmaceutical agents encapsulated with oils. This invention provides a uniform dispersion in an aqueous medium of droplets that include a core comprising water, a non-toxic C2-C5 alkanol, a water-soluble drug, and a surfactant. The coating surrounding the core consists of one or more pharmaceutically acceptable oils. This composition is particularly useful for the oral delivery of therapeutic agents due to its potential for taste masking, prolonged action, and protection of the drug against external environments and enzyme entrapment. Another significant patent is for aerosol drug formulations that utilize non-CFC propellants. This invention includes pharmaceutical compositions for aerosol delivery that comprise a medicament, a non-chlorofluorocarbon propellant, and a protective colloid. The method for preparing these compositions prevents particle aggregation without the use of surfactants or cosolvents.

Career Highlights

Mou-Ying Fu Lu is currently associated with Abbott Laboratories Corporation, where he continues to innovate in the pharmaceutical sector. His work has contributed to advancements in drug delivery systems, making medications more effective and safer for patients.

Collaborations

He has collaborated with notable coworkers such as Akwete L Adjei and Pramod K Gupta, further enhancing the impact of his research and inventions.

Conclusion

Mou-Ying Fu Lu's contributions to pharmaceutical innovations demonstrate his commitment to improving drug delivery systems. His patents reflect a deep understanding of the complexities involved in medication formulation and delivery.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…